Skip to main content

Published locations for New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial

User login

  • Reset your password
  • /content/new-engineered-hiv-1-vaccine-candidate-shows-improved-immunogenicity-early-trial
  • /idpractitioner/article/208303/hiv/new-engineered-hiv-1-vaccine-candidate-shows-improved
  • /internalmedicinenews/article/208303/hiv/new-engineered-hiv-1-vaccine-candidate-shows-improved
  • /jcomjournal/article/208303/hiv/new-engineered-hiv-1-vaccine-candidate-shows-improved-immunogenicity
  • /infectiousdisease/article/208303/hiv/new-engineered-hiv-1-vaccine-candidate-shows-improved
  • /internalmedicine/article/208303/hiv/new-engineered-hiv-1-vaccine-candidate-shows-improved